BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31937503)

  • 1. The therapeutic effect of treatment with RehaCom software on verbal performance in patients with multiple sclerosis.
    Arian Darestani A; Naeeni Davarani M; Hassani-Abharian P; Zarrindast MR; Nasehi M
    J Clin Neurosci; 2020 Feb; 72():93-97. PubMed ID: 31937503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RehaCom rehabilitation training improves a wide-range of cognitive functions in multiple sclerosis patients.
    Naeeni Davarani M; Arian Darestani A; Hassani-Abharian P; Vaseghi S; Zarrindast MR; Nasehi M
    Appl Neuropsychol Adult; 2022; 29(2):262-272. PubMed ID: 32368936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial.
    Messinis L; Nasios G; Kosmidis MH; Zampakis P; Malefaki S; Ntoskou K; Nousia A; Bakirtzis C; Grigoriadis N; Gourzis P; Papathanasopoulos P
    Behav Neurol; 2017; 2017():5919841. PubMed ID: 29463950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of computer-assisted cognitive rehabilitation in benign multiple sclerosis.
    Arsoy E; Tüzün E; Türkoğlu R
    Turk J Med Sci; 2018 Oct; 48(5):999-1005. PubMed ID: 30384567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of executive functioning to CVLT-II learning, memory, and process indexes.
    Hill BD; Alosco M; Bauer L; Tremont G
    Appl Neuropsychol Adult; 2012; 19(3):198-206. PubMed ID: 23373606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial.
    Rilo O; Peña J; Ojeda N; Rodríguez-Antigüedad A; Mendibe-Bilbao M; Gómez-Gastiasoro A; DeLuca J; Chiaravalloti N; Ibarretxe-Bilbao N
    Disabil Rehabil; 2018 Jan; 40(2):208-216. PubMed ID: 27927036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of pathological laughing and crying and cognitive impairment in multiple sclerosis.
    Hanna J; Feinstein A; Morrow SA
    J Neurol Sci; 2016 Feb; 361():200-3. PubMed ID: 26810543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief and cost-effective tool for assessing verbal learning in multiple sclerosis: Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test - II (CVLT-II).
    Beier M; Hughes AJ; Williams MW; Gromisch ES
    J Neurol Sci; 2019 May; 400():104-109. PubMed ID: 30913522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep and Cognitive Function in Multiple Sclerosis.
    Braley TJ; Kratz AL; Kaplish N; Chervin RD
    Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-order effects: a measure of verbal memory influences performance on a measure of verbal fluency.
    Lloyd KP; Higginson CI; Lating JM; Coiro MJ
    Appl Neuropsychol Adult; 2012; 19(4):299-304. PubMed ID: 23373642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Sex Matters: A Cognitive Study of People With Multiple Sclerosis.
    Donaldson E; Patel VP; Shammi P; Feinstein A
    Cogn Behav Neurol; 2019 Mar; 32(1):39-45. PubMed ID: 30896576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining verbal memory on the Word Memory Test and California Verbal Learning Test-Second Edition.
    Davis JJ; Wall JR
    Arch Clin Neuropsychol; 2014 Dec; 29(8):747-53. PubMed ID: 25064762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.
    Deckersbach T; Peters AT; Shea C; Gosai A; Stange JP; Peckham AD; Ellard KK; Otto MW; Rauch SL; Dougherty DD; Nierenberg AA
    J Affect Disord; 2018 Mar; 229():342-350. PubMed ID: 29331692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the California Verbal Learning Test-II in multiple sclerosis.
    Stegen S; Stepanov I; Cookfair D; Schwartz E; Hojnacki D; Weinstock-Guttman B; Benedict RH
    Clin Neuropsychol; 2010 Feb; 24(2):189-202. PubMed ID: 19953426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
    Gich J; Freixanet J; García R; Vilanova JC; Genís D; Silva Y; Montalban X; Ramió-Torrentà L
    Mult Scler; 2015 Sep; 21(10):1332-43. PubMed ID: 25716880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.
    Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Moiola L; Falautano M; De Caro MF; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Martinelli V; Comi G; Portaccio E; Trojano M;
    Neurology; 2010 Sep; 75(13):1134-40. PubMed ID: 20876467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results.
    Pitteri M; Dapor C; Pisani AI; Castellaro M; DeLuca J; Chiaravalloti N; Guandalini M; Ziccardi S; Calabrese M
    J Neuropsychol; 2020 Sep; 14(3):384-398. PubMed ID: 31785082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.